These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 31164192)

  • 1.
    Rantakokko-Jalava K; Hokynar K; Hieta N; Keskitalo A; Jokela P; Muotiala A; Jokiranta TS; Kuusela R; Sarkkinen H; Aittoniemi J; Vuorinen T; Hakanen AJ; Puolakkainen M
    Euro Surveill; 2019 May; 24(22):. PubMed ID: 31164192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Finnish new variant of
    Unemo M; Hansen M; Hadad R; Lindroth Y; Fredlund H; Puolakkainen M; Sundqvist M
    Euro Surveill; 2019 Jun; 24(26):. PubMed ID: 31266590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity, specificity, inclusivity and exclusivity of the updated Aptima Combo 2 assay, which provides detection coverage of the new diagnostic-escape Chlamydia trachomatis variants.
    Unemo M; Hansen M; Hadad R; Puolakkainen M; Westh H; Rantakokko-Jalava K; Thilesen C; Cole MJ; Boiko I; Lan PT; Golparian D; Ito S; Sundqvist M
    BMC Infect Dis; 2020 Jun; 20(1):419. PubMed ID: 32546213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chlamydia trachomatis Variants Escaping Detection in the Aptima Combo 2 Assay in the United States.
    Katz SS; Danavall DC; Morris MR; Herrod BP; Dale SE; Nye MB; Kersh EN; Kirkcaldy RD; Raphael BH
    Sex Transm Dis; 2022 Jun; 49(6):448-452. PubMed ID: 35171128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Chlamydia trachomatis 23S rRNA G1523A variant escaping detection in the Aptima Combo 2 assay (Hologic) was widespread across Denmark in July-September 2019.
    Hadad R; Jensen JS; Westh H; Grønbaek I; Schwartz LJ; Nielsen L; Vang TM; Nielsen R; Weinreich LS; Skov MN; Olsen M; Møller JK; Kolmos B; Unemo M; Hoffmann S
    APMIS; 2020 Jun; 128(6):440-444. PubMed ID: 32202687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of new variants of
    Roberts DJ; Davis GS; Cole MJ; Naik D; Maru H; Woodford N; Muir P; Horner P; Simms I; Thickett G; Crook P; Foster K; Andrews N; Saunders J; Fifer H; Folkard K; Gill ON;
    Euro Surveill; 2019 Sep; 24(38):. PubMed ID: 31552817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No widespread dissemination of
    Cole MJ; Davis GS; Fifer H; Saunders JM; Unemo M; Hadad R; Roberts DJ; Fazal M; Day MJ; Minshull J; Muir P; Horner PJ; Gill NO; Folkard K
    Sex Transm Infect; 2022 Aug; 98(5):366-370. PubMed ID: 34510008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Finnish New Variant of
    Hokynar K; Rantakokko-Jalava K; Hakanen A; Havana M; Mannonen L; Jokela P; Kurkela S; Lappalainen M; Unemo M; Puolakkainen M
    Microorganisms; 2019 Jul; 7(8):. PubMed ID: 31370214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the Abbott RealTime CT new formulation assay with two other commercial assays for detection of wild-type and new variant strains of Chlamydia trachomatis.
    Møller JK; Pedersen LN; Persson K
    J Clin Microbiol; 2010 Feb; 48(2):440-3. PubMed ID: 20007394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 'Finnish new variant of
    Johansen TB; Kløvstad H; Rykkvin R; Herrfurth-Erichsen EB; Sorthe J; Njølstad G; Ebbesen MH; Nygaard RM; Sandmoen EK; Thilesen C; Onken A; Liljedal I; Hadad R; Unemo M
    Euro Surveill; 2019 Oct; 24(42):. PubMed ID: 31640843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of Chlamydia trachomatis and Neisseria gonorrhoeae infections in North American women by testing SurePath liquid-based Pap specimens in APTIMA assays.
    Chernesky M; Freund GG; Hook E; Leone P; D'Ascoli P; Martens M
    J Clin Microbiol; 2007 Aug; 45(8):2434-8. PubMed ID: 17581931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of Chlamydia trachomatis by nucleic acid amplification testing: our evaluation suggests that CDC-recommended approaches for confirmatory testing are ill-advised.
    Schachter J; Chow JM; Howard H; Bolan G; Moncada J
    J Clin Microbiol; 2006 Jul; 44(7):2512-7. PubMed ID: 16825373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Gen-probe transcription-mediated amplification, Abbott PCR, and Roche PCR assays for detection of wild-type and mutant plasmid strains of Chlamydia trachomatis in Sweden.
    Møller JK; Pedersen LN; Persson K
    J Clin Microbiol; 2008 Dec; 46(12):3892-5. PubMed ID: 18842934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First report of performance of the Versant CT/GC DNA 1.0 assay (kPCR) for detection of Chlamydia trachomatis and Neisseria gonorrhoeae.
    Kerndt PR; Ferrero DV; Aynalem G; Monga D; Wang S; Zhang N; Wong C; Liggins M; Meng Q
    J Clin Microbiol; 2011 Apr; 49(4):1347-53. PubMed ID: 21307209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specimen processing and concentration of Chlamydia trachomatis added can influence false-negative rates in the LCx assay but not in the APTIMA Combo 2 assay when testing for inhibitors.
    Chong S; Jang D; Song X; Mahony J; Petrich A; Barriga P; Chernesky M
    J Clin Microbiol; 2003 Feb; 41(2):778-82. PubMed ID: 12574282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of urine testing in evaluations of the sensitivity of the Gen-Probe Aptima Combo 2 assay on endocervical swabs for Chlamydia trachomatis and neisseria gonorrhoeae: the infected patient standard reduces sensitivity of single site evaluation.
    Moncada J; Schachter J; Hook EW; Ferrero D; Gaydos C; Quinn TC; Willis D; Weissfeld A; Martin DH
    Sex Transm Dis; 2004 May; 31(5):273-7. PubMed ID: 15107628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the Gen-Probe APTIMA Combo 2 assay to the AMPLICOR CT/NG assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine samples from Australian men and women.
    Lowe P; O'Loughlin P; Evans K; White M; Bartley PB; Vohra R
    J Clin Microbiol; 2006 Jul; 44(7):2619-21. PubMed ID: 16825397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of an Aptima-format Finnish new variant of
    Weinbaum B; Williams A; Hadad R; Vinluan B; Puolakkainen M; Unemo M; Getman D
    Euro Surveill; 2020 Feb; 25(5):. PubMed ID: 32046818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The diagnostic-escape Finnish new variant of Chlamydia trachomatis first described in 2019 remains present in Finland three years after the introduction of an updated Aptima Combo 2 assay.
    Puolakkainen M; Mannonen L; Unemo M
    Clin Microbiol Infect; 2023 May; 29(5):658-659. PubMed ID: 36804908
    [No Abstract]   [Full Text] [Related]  

  • 20. High-volume workflow and performance comparisons for Chlamydia trachomatis and Neisseria gonorrhoeae testing using automated molecular platforms.
    Frontzek A; Aretzweiler G; Winkens D; Duncan D; Marlowe EM
    BMC Infect Dis; 2019 Sep; 19(1):797. PubMed ID: 31510949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.